Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (Carvedilol or Metoprolol)

American Journal of Cardiology

Volumn 92, Issue 5, 2003, Pages 548-553

  Blanchet, Martine ^a   Ducharme, Anique ^a   Racine, Normand ^a   Rouleau, Jean Lucien ^a   Tardif, Jean Claude ^a   Juneau, Martin ^a   Marquis, Johanne ^a   Larivée, Lucie ^a   Nigam, Anil ^a   Fortier, Anick ^a   White, Michel ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL TARTRATE; NORADRENALIN;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CLINICAL TRIAL; COLD EXPOSURE; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPNEA; ENDURANCE; EXERCISE; EXERCISE TEST; EXHAUSTION; FEMALE; GAS EXCHANGE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MEASUREMENT; NORADRENALIN BLOOD LEVEL; PARAMETER; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYMPTOMATOLOGY; TEMPERATURE; TIME;

EID: 17644440294     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00723-9     Document Type: Article

References (21)

1. Juneau M., Larivée L., White M. Cold temperature impairs maximal exercise performance in patients with heart failure attenuation by acute ACE inhibitor therapy . Can J Cardiol. 18:2002;981-986.
2. Sponer G., Bartsch W., Strein K., Muller-Beckmann B., Bohm E. Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties. J Cardiovasc Pharmacol. 9:1987;317-327.
3. Myers J., Buchanan N., Walsh D., Kraemer M., McAuley P., Hamilton-Wessler M., Froelicher V.F. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol. 17:1991;1334-1342.
4. Wasserman K., Hansen J.E., Sue D.Y., Casaburi R., Whipp B.J. Measurements during integrative cardiopulmonary exercise testing. Weinberg R. Principles of Exercise Testing and Interpretation. 1999;74-77 Lippincott Williams & Wilkins, Baltimore, MD.
5. Leon D.F., Amidi M., Leonard J.J. Left heart work and temperature responses to cold exposure in man. Am J Cardiol. 26:1970;38-45.
6. Hayward J.M., Holmes W.F., Gooden B.A. Cardiovascular responses in man to a stream of cold air. Cardiovasc Res. 10:1976;691-696.
7. Epstein S.E., Stampfer M., Beiser G.D., Goldstein R.E., Braunwald E. Effects of a reduction in environmental temperature on the circulatory response to exercise in man. N Engl J Med. 280:1969;7-11.
8. Marchant B., Donaldson G., Mridha K., Scarborough M., Timmis A.D. Mechanisms of cold intolerance in patients with angina. J Am Coll Cardiol. 23:1994;630-636.
9. Juneau M., Johnstone M., Dempsey E., Waters D.D. Exercise-induced myocardial ischemia in a cold environment. Effect of antianginal medications. Circulation. 79:1989;1015-1020.
10. Walsh J.T., Andrews R., Batin P.D., Cowley A.J. Haemodynamic and hormonal response to a stream of cooled air. Eur J Appl Physiol. 72:1995;76-80.
11. Arnett E.L., Watts D.T. Catecholamine excretion in men exposed to cold. J Appl Physiol. 15:1960;499-500.
12. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
13. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 349:1997;375-380.
14. Gilbert E.M., Abraham W.T., Olsen S., Hattler B., White M., Mealy P., Larrabee P., Bristow M.R. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 94:1996;2817-2825.
15. Gullestad L., Manhenke C., Aarsland T., Skardal R., Fagertun H., Wikstrand J., Kjekshus J. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial. Eur J Heart Failure. 3:2001;463-468.
16. Bristow M.R., Gilbert E.M., Abraham W.T., Adams K.F., Fowler M.B., Hershberger R.E., Kubo S.H., Narahara K.A., Ingersoll H., Krueger S., Young S., Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure (MOCHA). Circulation. 94:1996;2807-2816.
17. Metra M., Nodari S., Raccagni D., Garbellini M., Boldi E., Bontempi L., Gaiti M., Dei Cas L. Maximal and submaximal exercise testing in heart failure. J Cardiovasc Pharmacol. 32:(suppl 1):1998;S36-S45.
18. Metra M., Nardi M., Giubbini R., Dei Cas L. Effects of short- and long-term carvedilol adminstration on rest and exercise heamodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 24:1994;1678-1687.
19. Andersson B., Hamm C., Persson S., Wikstrom G., Sinagra G., Hjalmarson A., Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 23:1994;1397-1404.
20. Eichhorn E.J., Bedotto J.B., Malloy C.R., Hatfield B.A., Deitchman D., Brown M., Willard J.E., Grayburn P.A. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure. Circulation. 82:1990;473-483.
21. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 26:1995;1257-1263.